| Right ventricular function in ST elevation myocardial infarction: effect of reperfusion. | |
| | |
MedLine Citation:
|
PMID: 19640332 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: To investigate right ventricle function in successfully reperfused ST elevated myocardial infarction (STEMI) and to compare reperfusion strategies. METHODS: From January 2007 to August 2008, 33 patients with anterior myocardial infarction (MI) and 48 patients with non-anterior myocardial infarction were enrolled in this study. Patients were treated with thrombolytic therapy (TT) or primary percutanaeous coronary intervention (PPCI) (Primary intervention: 16 and 25 patients (anterior and non-anterior consecutively), thrombolytic therapy: 17 and 23 patients (anterior and non-anterior consecutively)). Right ventricle (RV) function was analyzed using tissue Doppler investigation (TDI) after 72 hr of successful reperfusion. RESULTS: There was no difference in right ventricle function assessed by right ventricle TDI Tei index between the PPCI and TT group (0.39+/-0.20 vs. 0.39+/-0,17). RV TDI Tei index increased in anterior MI patients treated with either PPCI or TT compared with control group (0.39+/-0.11 vs. 0.27+/-0.16, P=0.015 and 0.43+/-0.18 vs. 0.27+/-0.16 , P= 0.014 respectively). RV TDI Tei index did not differ between non-anterior MI patients treated with either PPCI or TT and control group (0.38+/-0.23 vs. 0.27+/-0.16, and 0.37+/-0.16 vs. 0.27+/-0.16, respectively). CONCLUSIONS: RV function deteriorated in STEMI compared with healthy controls. Contrary to the expectation, RV dysfunction was observed in anterior STEMI, but not in non anterior MI. There was no difference in RV function between the two treatment modalities. |
| | |
Authors:
|
Ozlem Karakurt; Ramazan Akdemir |
Publication Detail:
|
Type: Journal Article Date: 2009-08-01 |
Journal Detail:
|
Title: Clinical and investigative medicine. Médecine clinique et experimentale Volume: 32 ISSN: 1488-2353 ISO Abbreviation: Clin Invest Med Publication Date: 2009 |
Date Detail:
|
Created Date: 2009-07-30 Completed Date: 2009-10-08 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7804071 Medline TA: Clin Invest Med Country: Canada |
Other Details:
|
Languages: eng Pagination: E285-92 Citation Subset: IM |
Affiliation:
|
Ministry of Health, Diskapi Yildirim Beyazit Research and Education Hospital, Department of Cardiology, Ankara, Turkey. ozlemkarakurt55@yahoo.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Antagonists
/
therapeutic use Adult Aged Angioplasty, Transluminal, Percutaneous Coronary / methods Female Heptanoic Acids / therapeutic use Humans Male Metoprolol / analogs & derivatives, therapeutic use Middle Aged Myocardial Infarction / drug therapy, physiopathology*, therapy* Myocardial Reperfusion* Pyrroles / therapeutic use Streptokinase / therapeutic use Thrombolytic Therapy / methods Ticlopidine / analogs & derivatives, therapeutic use Treatment Outcome Ventricular Function, Right* / drug effects |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Antagonists; 0/Heptanoic Acids; 0/Pyrroles; 0/metoprolol succinate; 110862-48-1/atorvastatin; 37350-58-6/Metoprolol; 55142-85-3/Ticlopidine; 90055-48-4/clopidogrel; EC 3.4.-/Streptokinase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effect of simvastatin on plasma interleukin-6 in patients with unstable angina.
Next Document: Potential role of matrix metalloproteinase-2,-9 and tissue inhibitors of metalloproteinase-1,-2 in e...